A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- Citation:
- J Thorac Oncol vol 9 (2) 214-221
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 362
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA032291, CA33601, CA032291, U10 CA071323, CA77597, CA11789, U10 CA077658, CA77406, CA047559, CA32291, U10 CA086726, CA29165, U10 CA045564, CA41287, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA077597, CA45808, U10 CA114558, CA12046, U10 CA045418, CA86726, CA16450, U10 CA041287, CA45564, U10 CA047559, CA21060, P30 CA016058, CA47559, CA114558-02, CA47642, CA71323, CA45418, CA77658, CA77298, CA114558, U10 CA047642, CA31946
- Corr. Author:
- Authors:
- Rebecca S. Heist Xiaofei Wang Lydia Hodgson Gregory A. Otterson Thomas E. Stinchcombe Leena Gandhi Miguel A. Villalona-Calero Peter Watson Everett E. Vokes Mark A. Socinski
- Networks:
- Study
- CALGB-30704
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- CALGB 30704, Lung cancer